Literature DB >> 25395711

The effect of Astragalus extractive on alveolar bone rebuilding progress of tooth extracted socket of ovariectomied rats.

Xiaochen Liu1, Runju Zhang2, Yi Zhou1, Yanli Yang1, Hongling Si3, Xiaohong Li3, Li Liu1.   

Abstract

BACKGROUND: Postmenopausal osteoporosis (PMO) is an estrogen deficiency condition that causes severe loss of bone mass in the vertebrae and long bones. We explored the effect and the possible underlying mechanism of the extracts of Astragalus (AE) on the tooth alveolar bone rebuilding progress of postmenopausal osteoporosis of PMO animal models.
MATERIAL AND METHODS: The PMO models were acquired by ovariectomy. After 8 weeks the first left maxillary molars of the rats were extracted and AE was administered orally for 8 weeks. Then the histological morphology and the transcription and expression of TGF-β1 and TNF-α in the tooth extracted socket were detected by HE dying, QRT-PCR and ELISA.
RESULTS: The results showed that the new bone volume and TGF-β1 was significantly lower in PMO group than the control group and AE group at the observing period. At the same time TNF-α in PMO group was significantly higher than the other two groups. Moreover AE group had no significant differences with the control group in all data at the observing period.
CONCLUSION: AE has positive effect on alveolar bone rebuilding progress of tooth extracted socket of PMO rats. AE also has the potential to enhance the expression of TGF-β1 and decrease the expression of TNF-α of the rebuilding tooth extracted socket.

Entities:  

Keywords:  Astragalus; PMO; TGF-β1; TNF-α

Mesh:

Substances:

Year:  2014        PMID: 25395711      PMCID: PMC4202524          DOI: 10.4314/ajtcam.v11i5.15

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  46 in total

1.  Women's oral health issues.

Authors:  B J Steinberg
Journal:  J Dent Educ       Date:  1999-03       Impact factor: 2.264

2.  Changes in the bucco-lingual thickness of the mandibular alveolar process and skeletal bone mineral density in dentate women: a 5-yr prospective study.

Authors:  Grethe Jonasson; Stavros Kiliaridis
Journal:  Eur J Oral Sci       Date:  2005-04       Impact factor: 2.612

3.  Age and trabecular features of alveolar bone associated with osteoporosis.

Authors:  Byung Do Lee; Stuart C White
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2005-07

4.  Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways.

Authors:  Xianghuai Lu; Linda Gilbert; Xiaofei He; Janet Rubin; Mark S Nanes
Journal:  J Biol Chem       Date:  2006-01-12       Impact factor: 5.157

5.  Bone wound healing after maxillary molar extraction in ovariectomized aged rats.

Authors:  M Shimizu; T Sasaki; A Ishihara; R Furuya; T Kawawa
Journal:  J Electron Microsc (Tokyo)       Date:  1998

6.  Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women.

Authors:  J B Payne; R A Reinhardt; P V Nummikoski; K D Patil
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

7.  Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing.

Authors:  W Lehmann; C M Edgar; K Wang; T-J Cho; G L Barnes; S Kakar; D T Graves; J M Rueger; L C Gerstenfeld; T A Einhorn
Journal:  Bone       Date:  2005-02       Impact factor: 4.398

Review 8.  Osteoporosis: a still increasing prevalence.

Authors:  Jean-Yves Reginster; Nansa Burlet
Journal:  Bone       Date:  2006-02       Impact factor: 4.398

9.  Correlations between periodontitis and loss of mandibular bone in relation to systemic bone changes in postmenopausal Japanese women.

Authors:  Yoshitomo Takaishi; Yuko Okamoto; Takashi Ikeo; Hirotoshi Morii; Mitsuhiro Takeda; Kazukuni Hide; Tatsuo Arai; Kiichi Nonaka
Journal:  Osteoporos Int       Date:  2005-07-19       Impact factor: 4.507

10.  Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.

Authors:  K Kobayashi; N Takahashi; E Jimi; N Udagawa; M Takami; S Kotake; N Nakagawa; M Kinosaki; K Yamaguchi; N Shima; H Yasuda; T Morinaga; K Higashio; T J Martin; T Suda
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  6 in total

1.  Post-menopausal oestrogen deficiency induces osteoblast apoptosis via regulating HOTAIR/miRNA-138 signalling and suppressing TIMP1 expression.

Authors:  Shao-Yong Xu; Peng Shi; Rui-Ming Zhou
Journal:  J Cell Mol Med       Date:  2021-03-17       Impact factor: 5.310

2.  Zoledronic acid modulates osteoclast apoptosis through activation of the NF-κB signaling pathway in ovariectomized rats.

Authors:  Yu-Ting Cheng; Jian Liao; Qian Zhou; Hua Huo; Lucas Zellmer; Zheng-Long Tang; Hong Ma; Wei Hong; Dezhong Joshua Liao
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

3.  Systematic analysis of lncRNAs, miRNAs and mRNAs for the identification of biomarkers for osteoporosis in the mandible of ovariectomized mice.

Authors:  Lingyu Hao; Jiayao Fu; Yawen Tian; Junhua Wu
Journal:  Int J Mol Med       Date:  2017-07-10       Impact factor: 4.101

4.  PROTECTIVE EFFECT OF VANILLIC ACID ON OVARIECTOMY-INDUCED OSTEOPOROSIS IN RATS.

Authors:  Yong Gui Wang; Liang Bo Jiang; Bo Gou
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05

5.  Down-regulated microRNA-141 facilitates osteoblast activity and inhibits osteoclast activity to ameliorate osteonecrosis of the femoral head via up-regulating TGF-β2.

Authors:  Lei Tian; Shui Sun; Wei Li; Lin Yuan; Xianquan Wang
Journal:  Cell Cycle       Date:  2020-02-23       Impact factor: 4.534

6.  Cortical Bone Morphological and Trabecular Bone Microarchitectural Changes in the Mandible and Femoral Neck of Ovariectomized Rats.

Authors:  Pei-Yu Hsu; Ming-Tzu Tsai; Shun-Ping Wang; Ying-Ju Chen; Jay Wu; Jui-Ting Hsu
Journal:  PLoS One       Date:  2016-04-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.